Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.300
+0.070 (3.14%)
At close: Aug 13, 2025, 4:00 PM
2.300
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:18 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $87.54 million as of August 13, 2025. Its market cap has decreased by -68.20% in one year.
Market Cap
87.54M
Enterprise Value
-22.90M
1-Year Change
-68.20%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $87.54M, a decrease of -82.07%. That is a compound annual growth rate of -34.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 84.88M | -69.12% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |